Clinical Trial Update: Study of E7386 in Participants With Selected Advanced Neoplasms [Phase 1]

View source ↗

Summary

A status update for Eisai's Phase 1 study of E7386 in participants with selected advanced neoplasms, indicating the trial is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• E7386

Snippet

Sponsor: Eisai Inc. | Conditions: Advanced Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING